Edwards LifesciencesXSWX:EW +0.37%97 PEG Ratio is 6.04 as of Jun. 26, 2026, which is 74% above its 10-year median of 3.48. GuruFocus rates XSWX:EW with a GF Score™ of 97/100 and a GF Value™ of CHF75.73. The stock has 5 warning signs investors should review. Among 208 Medical Devices & Instruments companies, Edwards Lifesciences ranks worse than 84.13% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Edwards Lifesciences's PEG Ratio or its related term are showing as below:
XSWX:EW'
s PEG Ratio Range Over the Past 10 Years
Min: 1 Med: 3.48 Max: 389.45
Current: 5.93
During the past 13 years, Edwards Lifesciences's highest PEG Ratio was 389.45. The lowest was 1.00. And the median was 3.48.
XSWX:EW's PEG Ratio is ranked worse than 84.13% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.915
vs XSWX:EW: 5.93
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Edwards Lifesciences (XSWX:EW) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Edwards Lifesciences PEG Ratio Related Terms
Edwards Lifesciences PEG Ratio Historical Data
* Premium members only.
The historical data trend for Edwards Lifesciences's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Edwards Lifesciences's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edwards Lifesciences PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Edwards Lifesciences (XSWX:EW) has a PEG Ratio of 6.04 as of Jun. 26, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Edwards Lifesciences and its competitors. This is 74% above median its historical median of 3.48. Over the past decade, Edwards Lifesciences' PEG Ratio has ranged from 1.00 to 389.45. According to the industry distribution chart, Edwards Lifesciences ranks #175 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 84.1%.
Is Edwards Lifesciences' PEG Ratio too high?
Edwards Lifesciences' current PEG Ratio of 6.04 is 74% above median its 10-year median of 3.48. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 389.45. The Medical Devices & Instruments industry median PEG Ratio is 1.92. Edwards Lifesciences' value of 6.04 is 215.4% above this industry median. Based on the distribution chart, Edwards Lifesciences ranks #175 out of 208 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Edwards Lifesciences has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' PEG Ratio compare to DXCM and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Edwards Lifesciences ranks #175 out of 208 companies for PEG Ratio. This places Edwards Lifesciences in the lower half of its industry. The industry median PEG Ratio is 1.92. Edwards Lifesciences' value of 6.04 is 215.4% above this benchmark. Historically, Edwards Lifesciences' own PEG Ratio has ranged from 1.00 to 389.45 over the past decade. While the company's 10-year median is 3.48 vs. the industry median of 1.92, Edwards Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.92, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edwards Lifesciences's current PEG Ratio of 6.04 is 215.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Edwards Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edwards Lifesciences's current PEG Ratio is 6.04, which is 74% above median its own 10-year median of 3.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Edwards Lifesciences (XSWX:EW) has a current PEG Ratio of 6.04. The stock's GF Value™ is CHF75.73, compared to a current price of CHF72.91 — trading 3.7% below its estimated fair value. The current PEG Ratio is 6.04, which is 74% above median its 10-year median of 3.48 and 215.4% above the Medical Devices & Instruments industry median of 1.92. Edwards Lifesciences' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Edwards Lifesciences (XSWX:EW), the current PEG Ratio is 6.04 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edwards Lifesciences (XSWX:EW) Overvalued in 2026?
Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued.
The current stock price of CHF72.91 is trading 3.7% below its estimated GF Value™ of CHF75.73.
Key valuation signals for XSWX:EW:
PEG Ratio: 6.04 (74% above median its 10-year median of 3.48)
GF Value™: CHF75.73 vs. price of CHF72.91 (3.7% below fair value)
Industry Position: 215.4% above the Medical Devices & Instruments median (#175 of 208)
No single metric tells the full story. See the XSWX:EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
97GF Score
Get the complete analysis for XSWX:EW
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EW has been successfully added to your 
